Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavai

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 3, 2006
Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17beta-hydroxysteroid dehydrogenase type 3Brian E Fink, Ashvinikumar V Gavai, John S Tokarski, et al.
Journal of Integrative Bioinformatics|July 23, 2011
MADMAX - Management and analysis database for multiple ~omics experimentsKe Lin, Harrie Kools, Philip J de Groot, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2016
[2.2.1]-Bicyclic sultams as potent androgen receptor antagonistsWeifang Shan, Aaron Balog, Andrew Nation, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2007
Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinasesHarold Mastalerz, Ming Chang, Ashvinikumar Gavai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
Antitumor and antiangiogenic activities of BMS-690514, an inhibitor of human EGF and VEGF receptor kinase familiesTai W Wong, Francis Y Lee, Stuart Emanuel, et al.
Journal of Combinatorial Chemistry|December 18, 2008
Design and synthesis of a G-protein-coupled receptor antagonist library of aryloxyalkanolamines using a polymer-supported acyclic acetal linkerJacques Y Roberge, Lalgudi S Harikrishnan, Muthoni G Kamau, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2007
5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinasesHarold Mastalerz, Ming Chang, Ping Chen, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2021
Development of BET inhibitors as potential treatments for cancer: A search for structural diversityMatthew D Hill, Haiquan Fang, John Tokarski, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2007
New C-5 substituted pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinasesHarold Mastalerz, Ming Chang, Ping Chen, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2021
Development of BET inhibitors as potential treatments for cancer: A new carboline chemotypeMatthew D Hill, Claude Quesnelle, John Tokarski, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Bioorganic & Medicinal Chemistry Letters|January 3, 2006
Identification of a novel series of tetrahydrodibenzazocines as inhibitors of 17beta-hydroxysteroid dehydrogenase type 3Brian E Fink, Ashvinikumar V Gavai, John S Tokarski, et al.
Journal of Integrative Bioinformatics|July 23, 2011
MADMAX - Management and analysis database for multiple ~omics experimentsKe Lin, Harrie Kools, Philip J de Groot, et al.
Bioorganic & Medicinal Chemistry Letters|November 13, 2016
[2.2.1]-Bicyclic sultams as potent androgen receptor antagonistsWeifang Shan, Aaron Balog, Andrew Nation, et al.
Bioorganic & Medicinal Chemistry Letters|March 21, 2007
Novel C-5 aminomethyl pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinasesHarold Mastalerz, Ming Chang, Ashvinikumar Gavai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
Antitumor and antiangiogenic activities of BMS-690514, an inhibitor of human EGF and VEGF receptor kinase familiesTai W Wong, Francis Y Lee, Stuart Emanuel, et al.
Journal of Combinatorial Chemistry|December 18, 2008
Design and synthesis of a G-protein-coupled receptor antagonist library of aryloxyalkanolamines using a polymer-supported acyclic acetal linkerJacques Y Roberge, Lalgudi S Harikrishnan, Muthoni G Kamau, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2007
5-((4-Aminopiperidin-1-yl)methyl)pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinasesHarold Mastalerz, Ming Chang, Ping Chen, et al.
Bioorganic & Medicinal Chemistry Letters|May 15, 2021
Development of BET inhibitors as potential treatments for cancer: A search for structural diversityMatthew D Hill, Haiquan Fang, John Tokarski, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2007
New C-5 substituted pyrrolotriazine dual inhibitors of EGFR and HER2 protein tyrosine kinasesHarold Mastalerz, Ming Chang, Ping Chen, et al.
Bioorganic & Medicinal Chemistry Letters|September 24, 2021
Development of BET inhibitors as potential treatments for cancer: A new carboline chemotypeMatthew D Hill, Claude Quesnelle, John Tokarski, et al.
Pageof 8